Neuropathological alterations in Alzheimer disease

Cited by (1,028)

Items 801–900 of 1,028

1. Alzheimer’s, Parkinson’s Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement
   Maria Garofalo, Cecilia Pandini, Matteo Bordoni, Orietta Pansarasa, Federica Rey, Alfredo Cardoso Costa, Brigida Minafra, Luca Diamanti, Susanna Zucca, Stephana Carelli et al. · 2020 · International Journal of Molecular Sciences
2. Prospects for strain-specific immunotherapy in Alzheimer’s disease and tauopathies
   Bittar, Alice, Sengupta, Urmi, Kayed, Rakez · 2018 · npj Vaccines
3. Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease
   Jae Myeong Kang, Sang‐Yoon Lee, Seongho Seo, Hye Jin Jeong, Sung‐Ho Woo, Hyon Lee, Yeong‐Bae Lee, Byeong Kil Yeon, Dong Hoon Shin, Kee Hyung Park et al. · 2017 · Neurobiology of Aging
4. Lupeol, a Plant-Derived Triterpenoid, Protects Mice Brains against Aβ-Induced Oxidative Stress and Neurodegeneration
   Riaz Ahmad, Amjad Khan, Hyeon Jin Lee, Inayat Ur Rehman, Ibrahim Khan, Sayed Ibrar Alam, Myeong Ok Kim · 2020 · Biomedicines
5. Potential neurobiological links between social isolation and Alzheimer's disease risk
   Elizabeth Drinkwater, C. Davies, T. Spires-Jones · 2021 · European Journal of Neuroscience
6. Secretory Sorting Receptors Carboxypeptidase E and Secretogranin III in Amyloid β‐Associated Neural Degeneration in A lzheimer's Disease
   Virginia Plá, Sonia Paco, Grégory Ghézali, Victor Ciria, Esther Pozas, Isidró Ferrer, Fernando Aguado · 2012 · Brain Pathology
7. Apolipoprotein E Isoform-Specific Effects on Lipoprotein Receptor Processing
   Corbin J. Bachmeier, Ben Shackleton, Joseph O. Ojo, Daniel Paris, MICHAEL J. MULLAN, Fiona Crawford · 2014 · NeuroMolecular Medicine
8. Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer’s disease
   Md Golam Sharoar, Q Shi, Y Ge, Weifeng He, Xiangyou Hu, George L. Perry, Xiongwei Zhu, Riqiang Yan · 2015 · Molecular Psychiatry
9. Lithium and memantine improve spatial memory impairment and neuroinflammation induced by β-amyloid 1-42 oligomers in rats
   Josiane Budni, Daniel Proença Feijó, Hemily Batista-Silva, Michelle Lima Garcez, F. Mina, Tatiani Bellettini‐Santos, Lucas Ribeiro Krasilchik, Aline Pereira da Luz, Gustavo Luis Schiavo, João Quevedo · 2017 · Neurobiology of Learning and Memory
10. Reduced Walking Speed in Subjective and Mild Cognitive Impairment: A Cross-Sectional Study
    Mari Kalland Knapstad, Ole Martin Steihaug, Mona Kristin Aaslund, Arne Exner Nakling, Ingvill Fjell Naterstad, Tormod Fladby, Dag Aarsland, Lasse Melvaer Giil · 2018 · Journal of Geriatric Physical Therapy
11. Altered plasma arginine metabolome precedes behavioural and brain arginine metabolomic profile changes in the APPswe/PS1ΔE9 mouse model of Alzheimer’s disease
    DH Bergin, Jing Hong Yu, B. Mockett, H Zhang, Wickliffe C. Abraham, Pichuang Liu · 2018 · Translational Psychiatry
12. Application of Nanodiagnostics and Nanotherapy to CNS Diseases
    Weiyuan Zhang, Wenyue Wang, David Xiang Yu, Zhi‐Cheng Xiao, Zhiyong He · 2018 · Nanomedicine
13. Histone Deacetylase Inhibitors: A Therapeutic Key in Neurological Disorders?
    Małgorzata Ziemka‐Nałęcz, Joanna Jaworska, Joanna Sypecka, Teresa Zalewska · 2018 · Journal of Neuropathology & Experimental Neurology
14. The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice
    Johanna Michael, Julia Zirknitzer, Michael Stefan Unger, Rodolphe Poupardin, Tanja Rieß, Nadine Paiement, Horst Zerbe, Birgit Hutter‐Paier, Herbert Anton Reitsamer, Ludwig Aigner · 2021 · International Journal of Molecular Sciences
15. PROTAC technology for the treatment of Alzheimer’s disease: advances and perspectives
    Hiroyuki Inuzuka, Jing Liu, Wenyi Wei, Abdol-Hossein Rezaeian · 2022 · Acta Materia Medica
16. Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics
    Fancy, Nurun N., Smith, Amy M., Caramello, Alessia, Tsartsalis, Stergios, Davey, Karen, Muirhead, Robert C. J., McGarry, Aisling, Jenkyns, Marion H., Schneegans, Eleonore, Chau, Vicky et al. · 2024 · Acta Neuropathologica
17. Phytoconstituent plumbagin: Chemical, biotechnological and pharmaceutical aspects
    Hemant Ramachandra Badwaik, Leena Kumari, Kartik Tularam Nakhate, Vinay Sagar Verma, Kalyani Sakure · 2019 · Studies in natural products chemistry
18. Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer’s Disease Neuroimaging (ADNI) database
    Juan Felipe Beltrán, Brandon Malik Wahba, Nicole Hose, Dennis E. Shasha, Richard Kline, Alzheimer’s Disease Neuroimaging Initiative · 2020 · PLoS ONE
19. Effect of APOE alleles on the glial transcriptome in normal aging and Alzheimer’s disease
    Serrano-Pozo, Alberto, Li, Zhaozhi, Noori, Ayush, Nguyen, Huong N., Mezlini, Aziz, Li, Liang, Hudry, Eloise, Jackson, Rosemary J., Hyman, Bradley T., Das, Sudeshna · 2021 · Nature Aging
20. Island Study Linking Aging and Neurodegenerative Disease (ISLAND) Targeting Dementia Risk Reduction: Protocol for a Prospective Web-Based Cohort Study
    Larissa Bartlett, Kathleen Doherty, Maree Farrow, Sarang Kim, Edward Hill, Anna Elizabeth King, Jane Alty, Claire E. A. Eccleston, Alex Kitsos, Aidan David Bindoff et al. · 2021 · JMIR Research Protocols
21. Hallmarks of neurodegenerative disease: A systems pharmacology perspective
    Peter Bloomingdale, Tatiana Karelina, Vidya Ramakrishnan, Suruchi Bakshi, Florence Véronneau‐Veilleux, Matthew Moye, Kazutaka Sekiguchi, Guy M. L. Meno‐Tetang, Aparna Mohan, R. Maithreye et al. · 2022 · CPT Pharmacometrics & Systems Pharmacology
22. Levels of Alzheimer's disease blood biomarkers are altered after food intake—A pilot intervention study in healthy adults
    Hanna Huber, Nicholas James Ashton, Alina Schieren, Laia Montoliu‐Gaya, Guglielmo Di Molfetta, Wagner Scheeren Brum, Juan Lantero‐Rodriguez, Lana Grötschel, Birgit Stoffel‐Wagner, Martin Coenen et al. · 2023 · Alzheimer s & Dementia
23. Astrocytes in selective vulnerability to neurodegenerative disease
    Till S. Zimmer, Adam L. Orr, Anna G. Orr · 2024 · Trends in Neurosciences
24. The evolving landscape of Alzheimer’s disease therapy: From Aβ to tau
    Jean‐Philippe Courade, Henrik Zetterberg, Günter U. Höglinger, Ilse Dewachter · 2025 · Cell
25. Streptozotocin Induced Neurotoxicity Involves Alzheimer’s Related Pathological Markers: a Study on N2A Cells
    Joyshree Biswas, Poonam Goswami, Sonam Gupta, Neeraj Joshi, Chandishwar Nath, Sarika Singh · 2015 · Molecular Neurobiology
26. Involvement of glucose related energy crisis and endoplasmic reticulum stress: Insinuation of streptozotocin induced Alzheimer's like pathology
    Joyshree Biswas, Sonam Gupta, Dinesh Verma, Parul Gupta, Abhishek Singh, Shubhangini Tiwari, Poonam Goswami, Sharad Sharma, Sarika Singh · 2017 · Cellular Signalling
27. Frontal cortex and striatal cellular and molecular pathobiology in individuals with Down syndrome with and without dementia
    Sylvia E. Perez, Jennifer C. Miguel, Bin He, Michael H. Malek‐Ahmadi, Eric E. Abrahamson, Miloš D. Ikonomović, Ira T. Lott, Eric W. Doran, Melissa J. Alldred, Stephen D. Ginsberg et al. · 2019 · Acta Neuropathologica
28. Microbiota Alterations in Alzheimer’s Disease: Involvement of the Kynurenine Pathway and Inflammation
    Michelle Lima Garcez, Kelly R. Jacobs, Gilles J. Guillemin · 2019 · Neurotoxicity Research
29. Diabetes: Risk factor and translational therapeutic implications for Alzheimer's disease
    Jeffrey L. Cummings, Andrew Adonay Ortiz, Janelle Castellino, Jefferson W. Kinney · 2022 · European Journal of Neuroscience
30. The Role of Amyloid-Beta and Tau in the Early Pathogenesis of Alzheimer’s Disease
    Yin, Xiaomin, Qiu, Yanyan, Zhao, Chenhao, Zhou, Zheng, Bao, Junze, Qian, Wei · 2021 · Medical Science Monitor
31. Future Therapeutics in Alzheimer’s Disease: Development Status of BACE Inhibitors
    Genevieve M. Evin · 2016 · BioDrugs
32. Oxidative Stress in Alzheimer’s Disease: Molecular Hallmarks of Underlying Vulnerability
    Md. Sahab Uddin, Md. Tanvir Kabir · 2019 · Springer eBooks
33. Probenecid, an Old Drug with Potential New Uses for Central Nervous System Disorders and Neuroinflammation
    Claudia García‐Rodríguez, Paula Mujica, Javiera Illanes-González, Araceli López, Camilo Vargas, Juan Carlos Sáez, Arlek M. González‐Jamett, Álvaro O. Ardiles · 2023 · Biomedicines
34. Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity
    Alejandro Costoya‐Sánchez, Alexis Moscoso, Jesús Silva‐Rodríguez, Michael J. Pontecorvo, Michael D. Devous, Pablo Aguiar, Michael Schöll, Michel J. Grothe, Alzheimer’s Disease Neuroimaging Initiative, Michael Walter Weiner et al. · 2023 · JAMA Neurology
35. Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease
    Hyun‐Sik Yang, Ling Teng, Daniel Kang, Vilas Menon, Tian Ge, Hilary K. Finucane, Aaron P. Schultz, Michael J Properzi, Hans‐Ulrich Klein, Lori Beth Chibnik et al. · 2023 · Nature Communications
36. Icariin Prevents Amyloid Beta-Induced Apoptosis via the PI3K/Akt Pathway in PC-12 Cells
    Dongdong Zhang, Zhe Wang, Chenxia Sheng, Weijun Peng, Shan Hui, Wei Gong, Shuai Chen · 2015 · Evidence-based Complementary and Alternative Medicine
37. Regional and Gender Study of Neuronal Density in Brain during Aging and in Alzheimer's Disease
    Eva Martínez‐Pinilla, Cristina Ordóñez, Eva del Valle, Ana Navarro, Jorge Tolivia · 2016 · Frontiers in Aging Neuroscience
38. Wnt/TLR Dialog in Neuroinflammation, Relevance in Alzheimer’s Disease
    Juan Manuel Zolezzi, Nibaldo C. Inestrosa · 2017 · Frontiers in Immunology
39. Potential of Extracellular Vesicles in Neurodegenerative Diseases: Diagnostic and Therapeutic Indications
    Izadpanah, Mehrnaz, Seddigh, Arshia, Ebrahimi Barough, Somayeh, Fazeli, Seyed Abolhassan Shahzadeh, Ai, Jafar · 2018 · Journal of Molecular Neuroscience
40. Diet-Related Metabolic Perturbations of Gut Microbial Shikimate Pathway-Tryptamine-tRNA Aminoacylation-Protein Synthesis in Human Health and Disease
    Elena L. Paley · 2019 · International Journal of Tryptophan Research
41. A new Centiloid method for 18F-florbetaben and 18F-flutemetamol PET without conversion to PiB
    Soo Hyun Cho, Yeong Sim Choe, Hee Jin Kim, Hyemin Jang, Yeshin Kim, Si Eun Kim, Seung Joo Kim, Jun Pyo Kim, Young Hee Jung, Byeong Chae Kim et al. · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
42. The Effect of Dysfunctional Ubiquitin Enzymes in the Pathogenesis of Most Common Diseases
    Gizem Çelebi Torabfam, Hale Kesim, Ebru Ozer, Özlem Kutlu · 2020 · International Journal of Molecular Sciences
43. Polyamine biomarkers as indicators of human disease
    Mohsin Amin, Shiying Tang, Liliana Shalamanova, Rebecca L. Taylor, Stephen R. Wylie, Badr M. Abdullah, Kathryn A. Whitehead · 2021 · Biomarkers
44. The role of genetic risk factors of Alzheimer’s disease in synaptic dysfunction
    Fu, Wing-Yu, Ip, Nancy Y. · 2023 · Seminars in Cell & Developmental Biology
45. Spatial Memory and Gut Microbiota Alterations Are Already Present in Early Adulthood in a Pre-clinical Transgenic Model of Alzheimer’s Disease
    Paola Cristina Bello-Medina, Fernando Hernández-Quiroz, Marcel Pérez-Morales, Diego Alexander González-Franco, Guadalupe Cruz-Pauseno, Jaime Garcı́a-Mena, Sofía Y. Díaz-Cintra, Gustavo Pacheco‐López · 2021 · Frontiers in Neuroscience
46. Distinct types of amyloid‐β oligomers displaying diverse neurotoxicity mechanisms in Alzheimer's disease
    Priyanka Madhu, Samrat Mukhopadhyay · 2021 · Journal of Cellular Biochemistry
47. Role of Intracellular Amyloid β as Pathway Modulator, Biomarker, and Therapy Target
    Lucia Gallego Villarejo, Lisa Bachmann, David Marks, Maite Brachthäuser, Alexander Geidies, Thorsten Müller · 2022 · International Journal of Molecular Sciences
48. Withania somnifera (L.) Dunal (Ashwagandha); current understanding and future prospect as a potential drug candidate
    Javeed Ahmad Bhat, Tahira Akther, Rauf Ahmad Najar, Faheem Rasool, Abid Hamid · 2022 · Frontiers in Pharmacology
49. Cortical-blood vessel assembloids exhibit Alzheimer’s disease phenotypes by activating glia after SARS-CoV-2 infection
    Dasom Kong, Ki Hoon Park, Da‐Hyun Kim, Nam Gyo Kim, Seung‐Eun Lee, Nari Shin, Myung Geun Kook, Young Bong Kim, Kyung‐Sun Kang · 2023 · Cell Death Discovery
50. The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis
    Linyu Wu, Xiao‐Hui Xian, Zixuan Tan, Fang Dong, Guangyu Xu, Min Zhang, Feng Zhang · 2023 · Molecular Neurobiology
51. Faradarmani Consciousness Field Suppresses Alzheimer’s Disease Development in both in vitro and in vivo Models of the Disease
    Mohammad Ali Taheri, Sara Torabi, Noushin Nabavi, Farid Semsarha · 2022 · The Scientific Journal of Cosmointel
52. Reducing Aβ load and tau phosphorylation: Emerging perspective for treating Alzheimer's disease
    Jaspreet Kalra, Aamir Ghafoor Khan · 2015 · European Journal of Pharmacology
53. Brain metabolism and Alzheimer's disease: The prospect of a metabolite-based therapy
    Sean C. Thomas, Azhar A. Alhasawi, Vasu D. Appanna, C. Auger, Vasu D. Appanna · 2014 · The journal of nutrition health & aging
54. Specific Serotonergic Denervation Affects tau Pathology and Cognition without Altering Senile Plaques Deposition in APP/PS1 Mice
    Juan José Ramos‐Rodríguez, Sara M. Gil, Raquel Rey-Brea, Esther Berrocoso, Mónica Garcı́a-Alloza · 2013 · PLoS ONE
55. β-Hairpin of Islet Amyloid Polypeptide Bound to an Aggregation Inhibitor
    Ewa A. Mirecka, Sophie Feuerstein, Lothar Gremer, G.F. Schroeder, Matthias Stoldt, Dieter Willbold, Wolfgang Hoyer · 2016 · Scientific Reports
56. In Vivo Imaging of Microglia With Multiphoton Microscopy
    Carmen Hierro‐Bujalance, Brian J. Bacskai, Mónica Garcı́a-Alloza · 2018 · Frontiers in Aging Neuroscience
57. Dementia spectrum disorders: lessons learnt from decades with PET research
    Heather Wilson, Gennaro Pagano, Marios Politis · 2019 · Journal of Neural Transmission
58. Andrographolide Reduces Neuroinflammation and Oxidative Stress in Aged Octodon degus
    Carolina B. Lindsay, Juan Manuel Zolezzi, Daniela S. Rivera, Pedro Cisternas, Francisco Bozinovic, Nibaldo C. Inestrosa · 2019 · Molecular Neurobiology
59. Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest
    Farida Dakterzada, Ricard López Ortega, Alfonso Martínez Arias, Iolanda Riba Llena, Maria Ruiz-Julián, Raquel P Huerto, Nuria Tahan, Gerard Piñol‐Ripoll · 2021 · Frontiers in Aging Neuroscience
60. Following spatial Aβ aggregation dynamics in evolving Alzheimer’s disease pathology by imaging stable isotope labeling kinetics
    Wojciech Michno, Katie M. Stringer, Thomas Enzlein, Melissa K. Passarelli, Stéphane Escrig, Karina S. Vitanova, Jack I. Wood, Kaj Blennow, Henrik Zetterberg, Anders Meibom et al. · 2021 · Science Advances
61. A Review of Automated Techniques for Assisting the Early Detection of Alzheimer’s Disease with a Focus on EEG
    Eduardo Perez‐Valero, M. A. López-Gordo, Christian A. Morillas, Francisco J. Pelayo, Miguel A. Vaquero‐Blasco · 2021 · Journal of Alzheimer s Disease
62. Brain Exosomes: Friend or Foe in Alzheimer’s Disease?
    Sharanjot Kaur, Harkomal Verma, Monisha Dhiman, Gianluca Tell, Gian Luigi Gigli, Francesco Janes, Anil Kumar Mantha · 2021 · Molecular Neurobiology
63. Joint Semi-supervised and Active Learning for Segmentation of Gigapixel Pathology Images with Cost-Effective Labeling
    Zhengfeng Lai, Chao Wang, Luca Cerny Oliveira, Brittany N. Dugger, Sen-ching S. Cheung, Chen‐Nee Chuah · 2021 · IEEE International Conference on Computer Vision Workshops
64. Mechanism of synapse redox stress in Okadaic acid (ICV) induced memory impairment: Role of NMDA receptor
    Pradip Kumar Kamat, Shivika Rai, Supriya Swarnkar, Rakesh Shukla, Chandishwar Nath · 2014 · Neurochemistry International
65. Simultaneous evaluation of substrate-dependent oxygen consumption rates and mitochondrial membrane potential by TMRM and safranin in cortical mitochondria
    Subir Roy Chowdhury, Jelena Djordjevic, Benedict C. Albensi, Paul Fernyhough · 2015 · Bioscience Reports
66. Stress-Induced Synaptic Dysfunction and Neurotransmitter Release in Alzheimer’s Disease: Can Neurotransmitters and Neuromodulators be Potential Therapeutic Targets?
    Saurabh Kumar Jha, Niraj Kumar Jha, Dhiraj Kumar, Renu Sharma, Abhishek Shrivastava, Rashmi K. Ambasta, Pravir Kumar · 2016 · Journal of Alzheimer s Disease
67. Association of Neuropathological Markers in the Parietal Cortex With Antemortem Cognitive Function in Persons With Mild Cognitive Impairment and Alzheimer Disease
    Cyntia Tremblay, Arnaud François, Charlotte Delay, Laure Freland, Milène Vandal, David Alan Bennett, Frédéric Calon · 2017 · Journal of Neuropathology & Experimental Neurology
68. Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β
    Tanusree Sen, Pampa Saha, Nilkantha Sen · 2018 · Science Signaling
69. Tau pathology and neurochemical changes associated with memory dysfunction in an optimised murine model of global cerebral ischaemia - A potential model for vascular dementia?
    Sabah Khan, Nadira Y. Yuldasheva, Trevor F.C. Batten, Alasdair R. Pickles, Katherine A. B. Kellett, Sikha Saha · 2018 · Neurochemistry International
70. Phospho-Tau Changes in the Human CA1 During Alzheimer’s Disease Progression
    Mamen Regalado-Reyes, Diana Furcila, Félix Hernández, Jesús Ávila, Javier DeFelipe, Gonzalo León‐Espinosa · 2019 · Journal of Alzheimer s Disease
71. Presymptomatic Treatment With Andrographolide Improves Brain Metabolic Markers and Cognitive Behavior in a Model of Early-Onset Alzheimer’s Disease
    Pedro Cisternas, Carolina A. Oliva, Viviana I. Torres, Daniela P. Barrera, Nibaldo C. Inestrosa · 2019 · Frontiers in Cellular Neuroscience
72. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer’s mouse model
    Sitara B. Sankar, Carmen Infante‐Garcia, Laura D. Weinstock, Juan José Ramos‐Rodríguez, Carmen Hierro‐Bujalance, Cecilia M. Fernandez-Ponce, Levi Benjamin Wood, Mónica Garcı́a-Alloza · 2020 · Journal of Neuroinflammation
73. Prepulse inhibition of the acoustic startle reflex and P50 gating in aging and alzheimer’s disease
    Zahra Jafari, Bryan E Kolb, Majid H. Mohajerani · 2020 · Ageing Research Reviews
74. Interactions between Amyloid-Β Proteins and Human Brain Pericytes: Implications for the Pathobiology of Alzheimer’s Disease
    Donald J. Alcendor · 2020 · Journal of Clinical Medicine
75. Chrysin loaded lipid-core nanocapsules ameliorates neurobehavioral alterations induced by β-amyloid1-42 in aged female mice
    Renata Giacomeli, Marcelo Gomes de Gomes, Jéssica Brandão Reolon, Sandra Elisa Haas, Letícia Marques Colomé, Cristiano Ricardo Jessé · 2020 · Behavioural Brain Research
76. Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats
    Maricarmen Hernández Rodríguez, Ivonne Maciel Arciniega-Martínez, Iohanan Daniel García-Marín, José Correa‐Basurto, Martha Cecilia Rosales‐Hernández · 2020 · Molecular Neurobiology
77. Neuron loss associated with age but not Alzheimer's disease pathology in the chimpanzee brain
    Melissa K. Edler, Emily L. Munger, Richard S. Meindl, William Donald Hopkins, John J. Ely, JOSEPH M. ERWIN, Elliott Jay Mufson, Patrick R. Hof, Chet C. Sherwood, Mary Ann Raghanti · 2020 · Philosophical Transactions of the Royal Society B Biological Sciences
78. Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer’s disease
    Ryan J. Bevan, Timothy R. Hughes, Pete A. Williams, Mark A. Good, B. Paul Morgan, James E. Morgan · 2020 · Acta Neuropathologica Communications
79. Microglial VPS35 deficiency impairs Aβ phagocytosis and Aβ-induced disease-associated microglia, and enhances Aβ associated pathology
    Xiao Ren, Lingling Yao, YongGang Wang, Lin Mei, Wen‐Cheng Xiong · 2022 · Journal of Neuroinflammation
80. Altered DNA base excision repair profile in brain tissue and blood in Alzheimer’s disease
    Lillenes, Meryl S., Rabano, Alberto, Støen, Mari, Riaz, Tahira, Misaghian, Dorna, Møllersen, Linda, Esbensen, Ying, Günther, Clara-Cecilie, Selnes, Per, Stenset, Vidar T. V. et al. · 2016 · Molecular Brain
81. Historic concepts of dementia and Alzheimer's disease: From ancient times to the present
    Izabela Pereira Vatanabe, Patrícia Regina Manzine, Márcia R. Cominetti · 2019 · Revue Neurologique
82. Volume Analysis of Brain Cognitive Areas in Alzheimer’s Disease: Interim 3-Year Results from the ASCOMALVA Trial
    Enea Traini, Anna Carotenuto, Angiola Maria Fasanaro, Francesco Amenta · 2020 · Journal of Alzheimer s Disease
83. Coenzyme Q10, Ageing and the Nervous System: An Overview
    David Mantle, Robert A. Heaton, Iain Parry Hargreaves · 2021 · Antioxidants
84. Disentangling tau: One protein, many therapeutic approaches
    Courtney Lane‐Donovan, Adam L. Boxer · 2024 · Neurotherapeutics
85. Evidence that the presynaptic vesicle protein CSPalpha is a key player in synaptic degeneration and protection in Alzheimer’s disease
    Sachin Suresh Tiwari, Marie d’Orange, Claire Troakes, Badrun N Shurovi, Olivia Engmann, Wendy J. Noble, Tibor Hortobágyi, Karl-Peter Giese · 2015 · Molecular Brain
86. Amyloid Imaging: Poised for Integration into Medical Practice
    Keshav Anand, M. Sabbagh · 2016 · Neurotherapeutics
87. Inhibition of IKKβ by celastrol and its analogues – an in silico and in vitro approach
    Karpagam Veerappan, Sathishkumar Natarajan, Purushoth Ethiraj, Umashankar Vetrivel, Shila Samuel · 2016 · Pharmaceutical Biology
88. Captopril and Valsartan May Improve Cognitive Function Through Potentiation of the Brain Antioxidant Defense System and Attenuation of Oxidative/Nitrosative Damage in STZ-Induced Dementia in Rat
    Yasaman Arjmand Abbassi, Mohammad Taghi Mohammadi, Mahsa Sarami Foroshani, Javad Raouf Sarshoori · 2016 · Advanced Pharmaceutical Bulletin
89. Aberrant Wnt signaling: a special focus in CNS diseases
    Mercedes Arnés, Sergio Casas‐Tintó · 2017 · Journal of Neurogenetics
90. Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease
    Christopher Bi, Stephanie Bi, Bin Li · 2018 · Aging and Disease
91. Endothelins in inflammatory neurological diseases
    Pedro D’Orléans-Juste, Oscar Bate Akide Ndunge, Louisane Desbiens, Herbert Bernard Tanowitz, Mahalia S. Desruisseaux · 2018 · Pharmacology & Therapeutics
92. Extracellular heat shock proteins in neurodegenerative diseases: New perspectives
    Miles S. Lyon, Carol Milligan · 2019 · Neuroscience Letters
93. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
    Cameron Wells, Samuel E. Brennan, Matthew Keon, Nitin Saksena · 2019 · Frontiers in Molecular Neuroscience
94. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer’s disease
    Nora Bengoa‐Vergniory, Elisavet Velentza‐Almpani, Ana Maria Silva, Connor Scott, Mariana Vargas‐Caballero, Magdalena Sastre, Richard Wade‐Martins, Javier Alegre‐Abarrategui · 2021 · Acta Neuropathologica Communications
95. Challenges in sample preparation and structure determination of amyloids by cryo-EM
    Mara Zielinski, Christine Röder, G.F. Schroeder · 2021 · Journal of Biological Chemistry
96. Comparative neuropathology in aging primates: A perspective
    Carmen Freire‐Cobo, Melissa K. Edler, Merina Varghese, Emily L. Munger, Jessie Laffey, Sophia Raia, Selena S. In, Bridget A. Wicinski, Maria Medalla, Sylvia E. Perez et al. · 2021 · American Journal of Primatology
97. Genetically modified large animal models for investigating neurodegenerative diseases
    Yang, Weili, Chen, Xiusheng, Li, Shihua, Li, Xiao-Jiang · 2021 · Cell & Bioscience
98. Nanomedicines in the Management of Alzheimer’s Disease: Current View and Future Prospects
    Hitesh Chopra, Shabana Bibi, Inderbir Singh, Mohammad Amjad Kamal, Fahadul Islam, Fahad Abdulrahman Alhumaydhi, Talha Bin Emran, Simona Daniela Cavalu · 2022 · Frontiers in Aging Neuroscience
99. Disruption of nuclear envelope integrity as a possible initiating event in tauopathies
    Marine Prissette, Wen Fury, Matthew Koss, Claudia Racioppi, Daria Fedorova, Ella Dragileva, Georgia Clarke, Taylor Pohl, John Dugan, Diana Ahrens et al. · 2022 · Cell Reports
100. The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
     Kostes, William W., Brafman, David A. · 2023 · Cells